METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS
2024-04-11
专利权人CENT RES INST TUBERCULOSIS (RETU-Non-standard)
申请日期2024-04-11
专利号RU2830337-C1
成果简介NOVELTY - Invention refers to medicine, namely to phthisiology, and can be used in treating patients with pulmonary tuberculosis. In case of multiple drug resistance, a chemotherapy regimen is used for period of 18 months in the amount of: Bedaquiline 0.4 mg once day for 14 days, then 0.2 mg 3 times a week: monday, wednesday, friday, Linezolid 0.6 mg once a day, Moxifloxacin 0.4 mg once a day, Cycloserine 0.25 mg 3 times a day, Amikacin 1.0 g once a day, Pyrazinamide 0.5 mg 3 times a day. Inhalation therapy is carried out in parallel with anti-tuberculosis therapy for a period of time until regression of the tuberculosis process in the bronchi in the amount of: Dioxydin 1.5 ml + 2.0 ml of physiological solution 2 times a day through a nebuliser, Pulmicort 0.5 mg 2 times a day through a nebuliser. USE - Medicine. ADVANTAGE - Invention provides a wider range of technical means which can be used to treat patients with pulmonary tuberculosis, as well as higher clinical effectiveness in such patients. 1 cl, 3 dwg, 2 ex
IPC 分类号A61K-031/00 ; A61K-031/137 ; A61K-031/58 ; A61K-009/08 ; A61K-009/12 ; A61P-011/00 ; A61P-031/00
国家俄罗斯
专业领域化学化工
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/17240
专题中国科学院新疆生态与地理研究所
作者单位
CENT RES INST TUBERCULOSIS (RETU-Non-standard)
推荐引用方式
GB/T 7714
KOMISSAROVA O G,CHERNYKH N A,CHUMOVATOV N V,et al. METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS. RU2830337-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。